Dietary copper may ease heart disease

Mar 05, 2007

Including more copper in your everyday diet could be good for your heart, according to scientists at the University of Louisville Medical Center and the USDA Human Nutrition Research Center. Their studies show that giving copper supplements to mice eased the stress on their over-worked hearts by preventing heart enlargement. The study will be published online on March 5th in The Journal of Experimental Medicine.

Insufficient copper intake is associated with increases in cholesterol levels, clot formation, and heart disease. The new study found that feeding mice copper relieved heart disease and restored proper heart function, even when the animals' hearts were continually stressed. Stressed mice that were not given copper supplements suffered heart failure. The copper-rich diet increased the production of a protein that promotes the growth of new blood vessels, although exactly how this protein might aid heart recovery is not yet clear.

The human equivalent of the beneficial dose of copper used in this study is about 3.0 mg/day. The current recommended daily intake for humans, however, is only 0.9 mg/day. Increasing copper intake, especially in those pre-disposed to heart disease, might thus be an easy way to reduce the mortality rate associated with this condition.

Source: Journal of Experimental Medicine

Explore further: Simulation-based training improves endoscopy execution

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments : 0